Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vbi Vaccines Inc/bc (VBIV) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vbi Vaccines Inc/bc. Table 2 shows the detailed insider transactions. This company's CIK number is 764195.
Total stock buying since 2017: $66,734,622.
Total stock sales since 2017: $16,127,573.
Total stock option exercises since 2017: $15,942.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 609,090 | $1,004,998 | 10,894,749 | $1,475,603 | 0 | $0 |
| 2021 | 8,200 | $20,081 | 4,130,030 | $14,651,970 | 0 | $0 |
| 2020 | 9,090,909 | $9,999,999 | 0 | $0 | 0 | $0 |
| 2019 | 22,438,500 | $11,544,472 | 0 | $0 | 90,625 | $0 |
| 2018 | 15,791,785 | $22,188,262 | 0 | $0 | 134,375 | $0 |
| 2017 | 7,193,738 | $21,976,810 | 0 | $0 | 157,939 | $15,942 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-07 | 609,090 | $1,004,998 | 0 | $0 | 0 | $0 |
| 2023-04 | 0 | $0 | 10,894,749 | $1,475,603 | 0 | $0 |
| 2021-12 | 8,200 | $20,081 | 2,707,463 | $8,961,702 | 0 | $0 |
| 2021-06 | 0 | $0 | 1,422,567 | $5,690,268 | 0 | $0 |
| 2020-04 | 9,090,909 | $9,999,999 | 0 | $0 | 0 | $0 |
| 2019-10 | 62,000 | $30,496 | 0 | $0 | 0 | $0 |
| 2019-09 | 20,164,500 | $10,082,700 | 0 | $0 | 0 | $0 |
| 2019-06 | 2,212,000 | $1,431,276 | 0 | $0 | 90,625 | $0 |
| 2018-12 | 15,714,285 | $21,999,998 | 0 | $0 | 0 | $0 |
| 2018-08 | 32,600 | $65,927 | 0 | $0 | 0 | $0 |
| 2018-07 | 16,800 | $38,236 | 0 | $0 | 0 | $0 |
| 2018-06 | 0 | $0 | 0 | $0 | 134,375 | $0 |
| 2018-05 | 28,100 | $84,101 | 0 | $0 | 0 | $0 |
| 2017-12 | 10,000 | $38,850 | 0 | $0 | 0 | $0 |
| 2017-11 | 15,000 | $71,250 | 0 | $0 | 0 | $0 |
| 2017-10 | 7,155,738 | $21,825,000 | 0 | $0 | 0 | $0 |
| 2017-08 | 13,000 | $41,710 | 0 | $0 | 0 | $0 |
| 2017-06 | 0 | $0 | 0 | $0 | 151,562 | $0 |
| 2017-01 | 0 | $0 | 0 | $0 | 6,377 | $15,942 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-07-10 | Gillis Steven | Buy | 609,090 | 1.65 | 1,004,998 |
| 2023-04-06 | Edelman Joseph (10% Owner) | Sale | 4,251,563 | .11 | 467,671 |
| 2023-04-05 | Edelman Joseph (10% Owner) | Sale | 1,832,563 | .13 | 238,233 |
| 2023-04-04 | Edelman Joseph (10% Owner) | Sale | 4,810,623 | .16 | 769,699 |
| 2021-12-03 | Beattie Nell (Chief Business Officer) | Buy | 8,200 | 2.45 | 20,081 |
| 2021-12-01 | Edelman Joseph (10% Owner) | Sale | 2,707,463 | 3.31 | 8,961,702 |
| 2021-06-09 | Edelman Joseph (10% Owner) | Sale | 1,422,567 | 4.00 | 5,690,268 |
| 2020-04-24 | Edelman Joseph (10% Owner) | Buy | 9,090,909 | 1.10 | 9,999,999 |
| 2019-10-04 | Diaz-mitoma Francisco (Chief Medical Officer) | Buy | 40,000 | .50 | 20,000 |
| 2019-10-01 | Beattie Nell (Chief Business Officer) | Buy | 10,000 | .48 | 4,820 |
| 2019-10-01 | Mcnulty Christopher (CFO and Head of BD) | Buy | 12,000 | .47 | 5,676 |
| 2019-09-30 | Diaz-mitoma Francisco (Chief Medical Officer) | Buy | 14,500 | .50 | 7,250 |
| 2019-09-30 | Baxter Jeff (CEO, President) | Buy | 150,000 | .50 | 75,450 |
| 2019-09-23 | Edelman Joseph (10% Owner) | Buy | 20,000,000 | .50 | 10,000,000 |
| 2019-06-27 | Diaz-mitoma Francisco (Chief Medical Officer) | Buy | 8,000 | 1.07 | 8,560 |
| 2019-06-20 | Diaz-mitoma Francisco (Chief Medical Officer) | Buy | 52,000 | .83 | 43,420 |
| 2019-06-19 | Beattie Nell (Chief Business Officer) | Buy | 8,000 | .74 | 5,888 |
| 2019-06-19 | Baxter Jeff (CEO, President) | Buy | 144,000 | .73 | 105,408 |
| 2019-06-18 | Edelman Joseph (10% Owner) | Buy | 1,000,000 | .65 | 650,000 |
| 2019-06-17 | Edelman Joseph (10% Owner) | Buy | 1,000,000 | .62 | 618,000 |
| 2019-06-14 | Beattie Nell (Chief Business Officer) | Option Ex | 6,250 | .00 | 0 |
| 2019-06-14 | Anderson David Evander (Chief Scientific Officer) | Option Ex | 21,875 | .00 | 0 |
| 2019-06-14 | Baxter Jeff (CEO, President) | Option Ex | 31,250 | .00 | 0 |
| 2019-06-14 | Dewilde Michel | Option Ex | 12,500 | .00 | 0 |
| 2019-06-14 | Gillis Steven | Option Ex | 18,750 | .00 | 0 |
| 2018-12-17 | Kariv Tomer | Buy | 1,428,571 | 1.40 | 1,999,999 |
| 2018-12-13 | Edelman Joseph (10% Owner) | Buy | 14,285,714 | 1.40 | 19,999,999 |
| 2018-08-06 | Baxter Jeff (CEO, President) | Buy | 8,100 | 1.93 | 15,608 |
| 2018-08-03 | Beattie Nell (Chief Business Officer) | Buy | 2,000 | 2.01 | 4,011 |
| 2018-08-03 | Diaz-mitoma Francisco (Chief Medical Officer) | Buy | 6,000 | 2.10 | 12,600 |
| 2018-08-03 | Baxter Jeff (CEO, President) | Buy | 13,500 | 2.01 | 27,108 |
| 2018-08-02 | Diaz-mitoma Francisco (Chief Medical Officer) | Buy | 3,000 | 2.20 | 6,600 |
| 2018-07-31 | Baxter Jeff (CEO, President) | Buy | 16,800 | 2.28 | 38,236 |
| 2018-06-14 | Beattie Nell (Chief Business Officer) | Option Ex | 6,250 | .00 | 0 |
| 2018-06-14 | Requadt Scott | Option Ex | 12,500 | .00 | 0 |
| 2018-06-14 | Anderson David Evander (Chief Scientific Officer) | Option Ex | 21,875 | .00 | 0 |
| 2018-06-14 | Baxter Jeff (CEO, President) | Option Ex | 31,250 | .00 | 0 |
| 2018-06-14 | Dewilde Michel | Option Ex | 12,500 | .00 | 0 |
| 2018-06-14 | Rubin Steven D | Option Ex | 18,750 | .00 | 0 |
| 2018-06-14 | Logal Adam | Option Ex | 12,500 | .00 | 0 |
| 2018-06-14 | Gillis Steven | Option Ex | 18,750 | .00 | 0 |
| 2018-05-24 | Baxter Jeff (CEO, President) | Buy | 11,000 | 2.99 | 32,890 |
| 2018-05-11 | Diaz-mitoma Francisco (Chief Medical Officer) | Buy | 10,000 | 3.06 | 30,550 |
| 2018-05-11 | Baxter Jeff (CEO, President) | Buy | 7,100 | 2.91 | 20,661 |
| 2017-12-12 | Baxter Jeff (CEO, President) | Buy | 10,000 | 3.88 | 38,850 |
| 2017-11-28 | Baxter Jeff (CEO, President) | Buy | 15,000 | 4.75 | 71,250 |
| 2017-10-30 | Chawla Sam | Buy | 3,100,000 | 3.05 | 9,455,000 |
| 2017-10-30 | Gillis Steven | Buy | 300,000 | 3.05 | 915,000 |
| 2017-10-30 | Opko Health, Inc. (10% Owner) | Buy | 655,738 | 3.05 | 2,000,000 |
| 2017-10-26 | Edelman Joseph (10% Owner) | Buy | 3,100,000 | 3.05 | 9,455,000 |
| 2017-08-21 | Diaz-mitoma Francisco (Chief Medical Officer) | Buy | 3,000 | 3.17 | 9,510 |
| 2017-08-21 | Baxter Jeff (CEO, President) | Buy | 10,000 | 3.22 | 32,200 |
| 2017-06-14 | Beattie Nell (DCD) | Option Ex | 6,250 | .00 | 0 |
| 2017-06-14 | Requadt Scott | Option Ex | 12,500 | .00 | 0 |
| 2017-06-14 | Anderson David Evander (Chief Scientific Officer) | Option Ex | 21,875 | .00 | 0 |
| 2017-06-14 | Baxter Jeff (CEO, President) | Option Ex | 31,250 | .00 | 0 |
| 2017-06-14 | Buckley T. Adam (VP, Business Development) | Option Ex | 4,687 | .00 | 0 |
| 2017-06-14 | Dewilde Michel | Option Ex | 12,500 | .00 | 0 |
| 2017-06-14 | Chawla Sam | Option Ex | 12,500 | .00 | 0 |
| 2017-06-14 | Rubin Steven D | Option Ex | 18,750 | .00 | 0 |
| 2017-06-14 | Logal Adam | Option Ex | 12,500 | .00 | 0 |
| 2017-06-14 | Gillis Steven | Option Ex | 18,750 | .00 | 0 |
| 2017-01-17 | Gillis Steven | Option Ex | 6,377 | 2.50 | 15,942 |
Insider trading activities including stock purchases, stock sales, and option exercises of VBIV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vbi Vaccines Inc/bc (symbol VBIV, CIK number 764195) see the Securities and Exchange Commission (SEC) website.